Showing results (161-170 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|December 8, 2004
Myelofibrosis in primary myelodysplastic syndromes: clinical and biological significanceD Marisavljević, Z Rolović, V Cemerikić, et al.
Medical Oncology (Northwood, London, England)|December 8, 2004
Ifosfamide, mesna, and interferon-alpha2A combination chemoimmunotherapy in malignant mesothelioma: results of a single center in central anatoliaMustafa Altinbas, Ozlem Er, Metin Ozkan, et al.
Medical Oncology (Northwood, London, England)|December 8, 2004
Epithelioid sarcoma of vulva: a case report and review of the literatureKadri Altundag, Oguz Dikbas, Basak Oyan, et al.
Medical Oncology (Northwood, London, England)|August 10, 2004
Should mammographic screening be done in primary ovarian cancer?: A case control study in Turkish womenM Ozguroglu, B Avci, H Turna, et al.
Medical Oncology (Northwood, London, England)|August 10, 2004
The comparison of spontaneous LDH release activity from cultured PBMC with sera LDH activity in non-Hodgkin's lymphoma patientsV Jurisić, G Konjević, R Jancić-Nedeljkov, et al.
Medical Oncology (Northwood, London, England)|August 10, 2004
Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III StudyGeorge Fountzilas, Elisabeta Ciuleanu, Urania Dafni, et al.
Medical Oncology (Northwood, London, England)|August 10, 2004
Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancerTanweera S Khan, Anders Sundin, Claes Juhlin, et al.
Medical Oncology (Northwood, London, England)|August 10, 2004
Erythropoietin against cisplatin-induced peripheral neurotoxicity in ratsBulent Orhan, Suayib Yalcin, Gulay Nurlu, et al.
Medical Oncology (Northwood, London, England)|March 23, 2004
Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivoD M Vigushin, N Mirsaidi, G Brooke, et al.
Medical Oncology (Northwood, London, England)|March 23, 2004
Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase ii studyDaniele Santini, Cristian Massacesi, Rolando Maria D'Angelillo, et al.
Pageof 570